Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma
Kidney Med
.
2020 Apr 18;2(3):373-375.
doi: 10.1016/j.xkme.2020.01.012.
eCollection 2020 May-Jun.
Authors
Harish Seethapathy
1
,
Halla Bates
1
,
Donald F Chute
1
,
Ian Strohbehn
1
,
Samuel Strohbehn
1
,
Riley M Fadden
2
,
Kerry L Reynolds
2
,
Justine V Cohen
2
,
Ryan J Sullivan
2
,
Meghan E Sise
1
Affiliations
1
Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
2
Division of Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
PMID:
32734258
PMCID:
PMC7380350
DOI:
10.1016/j.xkme.2020.01.012
No abstract available
Grants and funding
K23 DK117014/DK/NIDDK NIH HHS/United States